SAFFRON HACKETT: Open Payments
NPI 1730728940 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 5 payments from 4 companies in 2025. Trend: 2023 $237 · 2024 $0 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $202 |
| UCB, Inc. | 1 | $108 |
| LEO Pharma Inc. | 1 | $52 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
Products named: DUPIXENT, ANZUPGO.
Industry payments across CA — which companies pay providers there.
